Your browser doesn't support javascript.
loading
Risk factors for non-adherence among people with HIV-associated TB in Karnataka, India: A case-control study.
Ranganath, T S; Kishore, S G; Reddy, Ramakrishna; Murthy, H J Deepak; Vanitha, B; Sharath, B N; Shewade, Hemant Deepak; Shekar, N Soma.
Affiliation
  • Ranganath TS; Department of Community Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
  • Kishore SG; Department of Community Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India. Electronic address: dr.kishoregowda@gmail.com.
  • Reddy R; Department of Community Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
  • Murthy HJD; Department of Community Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
  • Vanitha B; Department of Community Medicine, Bangalore Medical College and Research Institute, Bengaluru, Karnataka, India.
  • Sharath BN; Assistant Professor, Department of Community Medicine, ESIPGMC, Bengaluru, Karnataka, India.
  • Shewade HD; Independent Public Health Consultant, India.
  • Shekar NS; Director-National Tuberculosis Institute, India.
Indian J Tuberc ; 69(1): 65-72, 2022 Jan.
Article in En | MEDLINE | ID: mdl-35074153
SETTING: Five select districts of Karnataka, India, providing anti-tubercular and antiretroviral therapy (ATT and ART) to people with Human Immunodeficiency Virus (HIV) - associated Tuberculosis (TB) through a single window care approach at the ART centres (seven ART centres and 16 link ART centres). OBJECTIVES: To determine the factors associated with non-adherence to concurrent therapy. DESIGN: We conducted a case-control study involving primary and secondary data collection. Starting January 2019, we consecutively enrolled people on at least three months of ATT until we enrolled 125 cases (non-adherent to concurrent therapy) and 375 controls (adherent to concurrent therapy). Adherence was defined as taking >95% ART doses and >90% ATT doses, every month over the last three months. We performed multivariable logistic regression to identify factors associated with non-adherence. RESULTS: The mean age of the cases and control was similar: 39.8 (standard deviation: 8.8) years. The risk factors for non-adherence were status non-disclosure (aOR = 2.06), zidovudine-based ART (aOR = 4.87), >3 side effects (aOR = 6.45), not receiving counselling before ATT initiation (aOR = 5.25) and non-receipt of co-trimoxazole prophylaxis (aOR = 9.90). CONCLUSION: Major determinants for non-adherence were clinical and treatment related factors.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / HIV Infections Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans Country/Region as subject: Asia Language: En Journal: Indian J Tuberc Year: 2022 Document type: Article Affiliation country: India Country of publication: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tuberculosis / HIV Infections Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Child / Humans Country/Region as subject: Asia Language: En Journal: Indian J Tuberc Year: 2022 Document type: Article Affiliation country: India Country of publication: India